DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ratain MJ, Moslehi JJ, Lichter AS.
Ibrutinib's cardiotoxicity-an opportunity for postmarketing regulation.
JAMA Oncol 2021;
7 (02) 177-178
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.